What drives tumor growth? Is it a few rogue cells imposing their will upon healthy tissue, or diseased tissue bringing out the worst in otherwise peaceable cells? Or is it a back-and-forth, a dialogue ...
Pre-cancer cardiovascular risk factors and anthracycline-related cardiotoxicity among non-Hodgkin lymphoma survivors. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This ...
ROCKVILLE, Md.--(BUSINESS WIRE)--The National Foundation for Cancer Research (NFCR) announced today that Isaac P. Witz, Ph.D., has been selected to receive the 2023 Szent-Györgyi Prize for Progress in ...
Immunotherapy with pembrolizumab in surgically resectable head and neck squamous cell carcinoma. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does not include a ...